ENOV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ENOV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Enovis's change in receivables for the quarter that ended in Dec. 2023 was $-10 Mil. It means Enovis's Accounts Receivable increased by $10 Mil from Sep. 2023 to Dec. 2023 .
Enovis's change in receivables for the fiscal year that ended in Dec. 2023 was $-16 Mil. It means Enovis's Accounts Receivable increased by $16 Mil from Dec. 2022 to Dec. 2023 .
Enovis's Accounts Receivable for the quarter that ended in Dec. 2023 was $291 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Enovis's Days Sales Outstanding for the three months ended in Dec. 2023 was 58.45.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Enovis's liquidation value for the three months ended in Dec. 2023 was $-599 Mil.
The historical data trend for Enovis's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enovis Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | 49.92 | 42.69 | -110.99 | -45.19 | -16.32 |
Enovis Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Change In Receivables | Get a 7-Day Free Trial | -1.87 | -12.29 | -13.62 | 19.39 | -9.79 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enovis (NYSE:ENOV) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Enovis's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 291.483 | / | 455.02 | * | 91 |
= | 58.45 |
2. In Ben Graham's calculation of liquidation value, Enovis's accounts receivable are only considered to be worth 75% of book value:
Enovis's liquidation value for the quarter that ended in Dec. 2023 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 36.191 | - | 1088.633 | + | 0.75 * 291.483 | + | 0.5 * 468.832 |
= | -599 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Enovis's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
John Kleckner | officer: Principal Accounting Officer | 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808 |
Berry Phillip Benjamin (ben) | officer: SVP, Chief Financial Officer | 2711 CENTERVILLE ROAD SUITE 400, WILMINGTON DE 19808 |
Rajiv Vinnakota | director | 8730 STONY POINT PARKWAY, SUITE 150, RICHMOND VA 23235 |
A Clayton Perfall | director | |
Brady Shirley | officer: EVP, Colfax, Pres. & CEO, DJO | 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808 |
Patricia A Lang | officer: SVP, Chief HR Officer | C/O DIEBOLD NIXDORF, INCORPORATED, 5995 MAYFAIR ROAD, NORTH CANTON OH 44720 |
Bradley J Tandy | officer: SVP, General Counsel | P.O. BOX 587, 56 E. BELL DRIVE, WARSAW IN 46580 |
Daniel A Pryor | officer: SVP??Strategy & Business Deve. | DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006 |
Matthew L. Trerotola | director, officer: President & CEO | 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808 |
Christopher M Hix | officer: SVP, Chief Financial Officer | 2160 SATELLITE BLVD., SUITE 200, DULUTH GA 30097 |
Barbara W. Bodem | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Christine Ortiz | director | 1200 ABERNATHY ROAD, NE, SUITE 1200, ATLANTA GA 30328 |
Angela S Lalor | director | 3M CENTER, BLDG. 0220-09-E-02, ST PAUL MN 55144 1000 |
Shyam Kambeyanda | officer: ESAB President and SVP, Colfax | 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808 |
Douglas J. Pitts | officer: Controller, PAO | 100 MATSONFORD ROAD, RADNOR PA 19087 |
From GuruFocus
By Marketwired • 10-19-2023
By Value_Insider Value_Insider • 11-10-2022
By Value_Insider Value_Insider • 12-01-2022
By Value_Insider Value_Insider • 11-17-2022
By Marketwired • 07-06-2023
By sperokesalga sperokesalga • 02-27-2023
By GuruFocus Research • 06-03-2023
By Marketwired • 08-08-2023
By sperokesalga sperokesalga • 03-03-2023
By Marketwired • 06-28-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.